Seeking after more favorable agents, a compound of small-molecule PSMA was developed (68Ga-labelled HBED-CC conjugate), which showed more affinity and specificity in binding to the PSMA-expressing PCa cells [80]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.